Company: RCUS
Filing Date: 2025-06-12
Form Type: 8-K
Source: 0001724521-25-000078
Chunk: 0

Company: Arcus Biosciences, Inc.
Filing Date: 2025-06-12
Form: 8-K
Item: Item 5.07
Chunk 0
---
Item 5.07 Submission of Matters to a Vote of Security Holders

On June 10, 2025, Arcus Biosciences, Inc. (the "Company") held its annual meeting of stockholders. The results of the stockholder votes on each proposal brought before the Annual Meeting is as follows:

Proposal 1: The election of Class I directors to hold office until the 2028 Annual Meeting of Stockholders and until its successor is duly elected and qualified:

  Nominee                            Votes For      Votes Withheld      Broker Non-Votes  
 ──────────────────────────────────────────────────────────────────────────────────────────
  Yasunori Kaneko, M. D.            86,171,508           4,142,191             8,580,999  
  Patrick Machado, J. D.            72,358,392          17,955,307             8,580,999  
  Andrew Perlman, M. D., Ph. D      84,672,810           5,640,889             8,580,999  
  Antoni Ribas, M. D., Ph. D.       74,827,393          15,486,306             8,580,999  

Proposal 2: The ratification of the selection by the Audit Committee of the Company's Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025:

   Votes For      Votes Against      Abstentions  
 ──────────────────────────────────────────────────
  96,750,327          1,952,359          192,012  

Proposal 3: The approval, on an advisory basis, of the compensation of the Company's named executive officers as disclosed in the Proxy Statement:

   Votes For      Votes Against      Abstentions      Broker Non-Votes  
 ────────────────────────────────────────────────────────────────────────
  84,812,809          5,446,383           54,507             8,580,999  

Item 8.01 Other Events.